Shopping Cart
- Remove All
- Your shopping cart is currently empty
CBL0137 (Curaxin 137), a metabolically stable curaxin, activates p53 (EC50: 0.37 μM) and inhibits NF-κB (EC50: 0.47 μM). It functionally inactivates the facilitates chromatin transcription complex (FACT), driving the effects on p53 and NF-κB and promoting cancer cell death. CBL0137 has broad anticancer activity in mice when administered orally, eradicates drug-resistant cancer stem cells, and potentiates the efficacy of gemcitabine in preClinicalal models of pancreatic cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 41 € | In Stock | |
5 mg | 128 € | In Stock | |
10 mg | 206 € | In Stock | |
25 mg | 414 € | In Stock | |
50 mg | 561 € | In Stock | |
100 mg | 747 € | In Stock | |
1 mL x 10 mM (in DMSO) | 126 € | In Stock |
Description | CBL0137 (Curaxin 137), a metabolically stable curaxin, activates p53 (EC50: 0.37 μM) and inhibits NF-κB (EC50: 0.47 μM). It functionally inactivates the facilitates chromatin transcription complex (FACT), driving the effects on p53 and NF-κB and promoting cancer cell death. CBL0137 has broad anticancer activity in mice when administered orally, eradicates drug-resistant cancer stem cells, and potentiates the efficacy of gemcitabine in preClinicalal models of pancreatic cancer. |
Targets&IC50 | NF-κB:0.47 μM (EC50), p53:0.37 μM (EC50) |
Alias | Curaxin 137, CBLC137 |
Molecular Weight | 336.43 |
Formula | C21H24N2O2 |
Cas No. | 1197996-80-7 |
Smiles | C(CNC(C)C)N1C=2C(C=3C1=CC=C(C(C)=O)C3)=CC(C(C)=O)=CC2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 25 mg/mL (74.31 mM), Sonication is recommended. H2O: Insoluble | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.